threats < three < threshold

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]

Ident.	Authors (with country if any)	Title
000032 (2010)	Daichi Inoue [Japon] ; Hiroshi Arima [Japon] ; Chiharu Kawanami [Japon] ; Yoko Takiuchi [Japon] ; Seiji Nagano [Japon] ; Takaharu Kimura [Japon] ; Sonoko Shimoji [Japon] ; Minako Mori [Japon] ; Sumie Tabata [Japon] ; Soshi Yanagita [Japon] ; Akiko Matsushita [Japon] ; Kenichi Nagai [Japon] ; Yukihiro Imai [Japon] ; Takayuki Takahashi [Japon]	Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis
000049 (2012)	Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]	Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000085 (2011)	Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]	Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000088 (2011)	Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis]	Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
000091 (2012)	Sooha Kim [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]	Interleukin-6 and cytochrome-P450, reason for concern?
000130 (2007)	Gerald Gartlehner [Autriche, États-Unis] ; Richard A. Hansen [États-Unis] ; Beth L. Jonas [États-Unis] ; Patricia Thieda [États-Unis] ; Kathleen N. Lohr [États-Unis]	Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
000149 (2010)	J. Wollenhaupt [Allemagne] ; K. Krüger [Allemagne]	Nicht-TNF-Biologika in der Therapiestrategie bei rheumatoider Arthritis
000190 (2008)	N. Leuchten [Allemagne] ; M. Aringer [Allemagne]	Rheumatoide Arthritis/chronische Polyarthritis heute
000193 (2012)	L. K. King ; A. Lee [Australie] ; A. Anandacoomarasamy [Australie]	Use of biological disease‐modifying anti‐rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B
000195 (2010)	Luciana Breda [Italie] ; Marianna Del Torto [Italie] ; Sara De Sanctis [Italie] ; Francesco Chiarelli [Italie]	Biologics in children’s autoimmune disorders: efficacy and safety
000196 (2008)	Y. Shirota [États-Unis] ; Gg Illei [États-Unis] ; Np Nikolov [États-Unis]	Biologic treatments for systemic rheumatic diseases
000223 (2010)	J. Möller [Allemagne] ; H. J. Girschick [Allemagne] ; G. Hahn [Allemagne] ; F. Pessler [Allemagne]	Kortikosteroid-induzierte spinale epidurale Lipomatose bei pädiatrischen Patienten
000241 (2010)	Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Satoshi Terae [Japon] ; Hiroki Shirato [Japon]	Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study
000323 (2013)	P. I. Novikov [Russie] ; I. O. Smitienko [Russie] ; S. V. Moiseev [Russie]	Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature
000421 (2013)	P. N. Morcos [États-Unis] ; S. A. Moreira [États-Unis] ; B. J. Brennan [États-Unis] ; S. Blotner [États-Unis] ; N. S. Shulman [États-Unis] ; P. F. Smith [États-Unis]	Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate
000461 (2011)	Alberto Migliore [Italie, Espagne] ; Emanuele Bizzi [Italie] ; Serena Broccoli [Italie] ; Bruno Laganà [Italie]	Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator
000462 (2013)	Reinhard P. T. Rychlik [Allemagne]	Target patient population: how does the regulatory and reimbursement view differ? Insights from the German IQWiG
000466 (2009)	Taio Naniwa [Japon] ; Maiko Watanabe [Japon] ; Shogo Banno [Japon] ; Tomoyo Maeda [Japon]	Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies
000535 (2013)	Oliver Foot ; Anshuman Malaviya	Treatment of rheumatoid arthritis: current and future
000611 (2013)	K. Saito [Japon] ; K. Hanami [Japon] ; S. Hirata [Japon] ; S. Kubo [Japon] ; M. Nawata [Japon] ; K. Yamaoka [Japon] ; S. Nakayamada [Japon] ; K. Nakano [Japon] ; Y. Tanaka [Japon]	FRI0251 Comparison of lipid profile including high molecular weight adiponectin (HMW-AN) after treatment with three different biologics in the patients with bio-naïve rheumatoid arthritis (RA)
000636 (2013)	M. Bodro [Espagne, Australie] ; D. L. Paterson [Australie]	Listeriosis in patients receiving biologic therapies

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "three" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "three" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    three
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021